Asher A Chanan-Khan

Asher A Chanan-Khan

UNVERIFIED PROFILE

Are you Asher A Chanan-Khan?   Register this Author

Register author
Asher A Chanan-Khan

Asher A Chanan-Khan

Publications by authors named "Asher A Chanan-Khan"

Are you Asher A Chanan-Khan?   Register this Author

66Publications

2221Reads

32Profile Views

Survival trends in glioblastoma and association with treating facility volume.

J Clin Neurosci 2019 Oct 24;68:271-274. Epub 2019 May 24.

Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2019.04.028DOI Listing
October 2019

Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet Haematol 2017 Nov 25;4(11):e534-e543. Epub 2017 Sep 25.

Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1, Sapienza University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(17)30168-0DOI Listing
November 2017

Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma.

JCO Precis Oncol 2017 1;2017. Epub 2017 Aug 1.

David L. Marks, Tara L. Hogenson, Anne M. Vrabel, Ashley N. Sigafoos, Ezequiel J. Tolosa, Ryan M. Carr, Stephanie L. Safgren, Elisa Enriquez Hesles, Luciana L. Almada, Paola A. Romecin-Duran, Eriko Iguchi, Aryan Ala'Aldeen, Jean-Pierre A. Kocher, Gavin R. Oliver, Naresh Prodduturi, David W. Mead, Asif Hossain, Norine E. Huneke, Colleen M. Tagtow, Sikander Ailawadhi, Stephen M. Ansell, Michaela S. Banck, Asher A. Chanan-Khan, Ronald S. Go, Thorvardur R. Halfdanarson, Richard W. Joseph, Prashant Kapoor, Aaron S. Mansfield, Amulya A. Nageswara Rao, Grzegorz S. Nowakowski, Animesh Pardanani, Sameer A. Parikh, John C. Cheville, Andrew L. Feldman, Ramesh K. Ramanathan, Steven I. Robinson, Heidi D. Finnes, Jennifer B. McCormick, Robert R. McWilliams, Aminah Jatoi, Mrinal M. Patnaik, Eric D. Wieben, Tammy M. McAllister, Kandelaria M. Rumilla, Sarah E. Kerr, Konstantinos N. Lazaridis, Gianrico Farrugia, Karl J. Clark, Eric W. Klee, and Martin E. Fernandez-Zapico, Mayo Clinic, Rochester; Ernesto Resnik, Bio-Techne, Minneapolis, MN; Sikander Ailawadhi, Asher A. Chanan-Khan, and Richard W. Joseph, Mayo Clinic, Jacksonville, FL; Jan B. Egan, Alan H. Bryce, Estrella M. Carballido, KellyK. Curtis, Chelsea D. Gawryletz, Thai H. Ho,Nathalie Meurice, Ramesh K. Ramanathan, Raoul Tibes, Alvin C. Silva, A. Keith Stewart, and Mitesh J. Borad, Mayo Clinic, Phoenix, AZ; and Eileen J. Kennedy, University of Georgia, Athens, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.17.00018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369924PMC
August 2017

Outcome disparities among ethnic subgroups of Waldenström's macroglobulinemia: a population-based study.

Oncology 2014 4;86(5-6):253-62. Epub 2014 Jun 4.

Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Fla., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000360992DOI Listing
September 2014

Multiple myeloma and immunomodulation: regulating the regulatory cells.

Leuk Lymphoma 2012 Jul 3;53(7):1253-4. Epub 2012 Apr 3.

Cancer Basic Science, Mayo Clinic, Jacksonville, FL 32224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.670233DOI Listing
July 2012

Novel therapeutic agents for the management of patients with multiple myeloma and renal impairment.

Clin Cancer Res 2012 Apr 10;18(8):2145-63. Epub 2012 Feb 10.

Roswell Park Cancer Institute, Buffalo, and Tisch Cancer Institute, Mount Sinai Medical Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-11-0498DOI Listing
April 2012

Development of target-specific treatments in multiple myeloma.

Br J Haematol 2010 Oct 7;151(1):3-15. Epub 2010 Jul 7.

Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2010.08262.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698607PMC
October 2010

Importance of achieving a complete response in multiple myeloma, and the impact of novel agents.

J Clin Oncol 2010 May 12;28(15):2612-24. Epub 2010 Apr 12.

Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.25.4250DOI Listing
May 2010

Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types.

J Exp Clin Cancer Res 2010 Jan 22;29. Epub 2010 Jan 22.

Departments of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-9966-29-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826345PMC
January 2010

Targeting the Bcl-2.

Curr Opin Oncol 2009 Nov;21(6):516-23

Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e328331a7a4DOI Listing
November 2009

The many lives of thalidomide.

Leuk Lymphoma 2009 Jun;50(6):861-2

Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190902964784DOI Listing
June 2009

Lenalidomide for the treatment of B-cell malignancies.

J Clin Oncol 2008 Mar 19;26(9):1544-52. Epub 2008 Feb 19.

Roswell Park Cancer Institute, Buffalo, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.14.5367DOI Listing
March 2008

Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma.

Blood 2007 Nov 25;110(9):3281-90. Epub 2007 Jun 25.

Lineberger Comprehensive Cancer Center and Department of Medicine, Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-01-065888DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2200918PMC
November 2007

New treatments for chronic lymphocytic leukemia.

Curr Oncol Rep 2007 Sep;9(5):353-60

Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-007-0047-7DOI Listing
September 2007

Clinical impact of bortezomib in frontline regimens for patients with multiple myeloma.

Oncologist 2007 Aug;12(8):978-90

Department of Medicine, Roswell Park Cancer Institute, Elm & Carlton Street, Buffalo, New York 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.12-8-978DOI Listing
August 2007

Bcl-2 antisense therapy in multiple myeloma.

Oncology (Williston Park) 2004 Nov;18(13 Suppl 10):21-4

Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.

View Article

Download full-text PDF

Source
November 2004